Non-interventional Study of Pomalidomide (Imnovid) in Combination With Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

Trial Profile

Non-interventional Study of Pomalidomide (Imnovid) in Combination With Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 02 May 2017

At a glance

  • Drugs Pomalidomide (Primary) ; Dexamethasone
  • Indications Multiple myeloma
  • Focus Therapeutic Use
  • Acronyms Poseidon
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 26 Apr 2017 Planned End Date changed from 1 Sep 2020 to 1 Mar 2021.
    • 26 Apr 2017 Planned primary completion date changed from 1 Jul 2020 to 1 Mar 2021.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top